The estrogenic effect of bisphenol a disrupts pancreatic β-cell function in vivo and induces insulin resistance

Environmental Health Perspectives

Volumn 114, Issue 1, 2006, Pages 106-112

  Alonso Magdalena, Paloma ^a   Morimoto, Sumiko ^a,b   Ripoll, Cristina ^a   Fuentes, Esther ^a   Nadal, Angel ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Bisphenol A; Diabetes; Endocrine disruptors; Estradiol; Estrogen receptor; Insulin; Islet of Langerhans; Nongenomic; Xenoestrogens

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ESTRADIOL; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR; GLUCOSE; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CHRONIC DISEASE; CONTROLLED STUDY; CORRELATION FUNCTION; DYSLIPIDEMIA; ENVIRONMENTAL EXPOSURE; ESTROGEN ACTIVITY; GENOMICS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HYPERINSULINEMIA; HYPERTENSION; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RISK ASSESSMENT;

ANIMALS; BLOOD GLUCOSE; ESTROGENS, NON-STEROIDAL; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MALE; MICE; PHENOLS;

ANIMALIA;

EID: 30344444488     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.8451     Document Type: Article

References (57)

1. Adachi T, Yasuda K, Mori C, Yoshinaga M, Aoki N, Tsujimoto G, et al. 2005. Promoting insulin secretion in pancreatic islets by means of bisphenol A and nonylphenol via intracellular estrogen receptors. Food Chem Toxicol 43:713-719.
2. 2+ signals in pancreatic α-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans. Environ Health Perspect 113:969-977; doi:10.1289/ehp.8002 [Online 18 May 2005].
3. Amiel SA, Caprio S, Sherwin RS, Plewe G, Haymond MW, Tamborlane WV. 1991. Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab 72:277-282.
4. Bertazzi PA, Consonni D, Bachetti S, Rubagotti M, Baccarelli A, Zocchetti C, et al. 2001. Health effects of dioxin exposure: a 20-year mortality study. Am J Epidemiol 153:1031-1044.
5. Bisphenol A Global Industry Group. 2005. Bisphenol A Homepage. Arlington VA:Bisphenol A Global Industry Group of the American Plastics Council. Available: http://www.bisphenol-a.org/ [accessed 31 August 2005].
6. Brotons JA, Olea-Serrano MF, Villalobos M, Pedraza V, Olea N. 1995. Xenoestrogens released from lacquer coatings in food cans. Environ Health Perspect 103:608-612.
7. Charollais A, Gjinovci A, Huarte J, Bauquis J, Nadal A, Martin F, et al. 2000. Junctional communication of pancreatic beta cells contributes to the control of insulin secretion and glucose tolerance. J Clin Invest 106:235-243.
8. Colborn T, Myers JP, Dubanowsky D. 1996. Our Stolen Future. New York:Dutton.
9. Colborn T, vom Saal FS, Soto AM. 1993. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 101:378-384.
10. Contreras JL, Smyth CA, Bilbao G, Young CJ, Thompson JA, Eckhoff DE. 2002. 17β-Estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: molecular mechanisms and islet functionality. Transplantation 74:1252-1259.
11. Costrini NV, Kalkhoff RK. 1971. Relative effects of pregnancy, estradiol, and progesterone on plasma insulin and pancreatic islet insulin secretion. J Clin Invest 50:992-999
12. DeFronzo RA. 1997. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 5:178-269.
13. DeFronzo RA, Ferrannini E. 1991. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-94.
14. Del Prato S, Leonetti F, Simonson DC, Sheehan P, Matsuda M, DeFronzo RA. 1994. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia 37:1025-1035.
15. Devedjian JC, George M, Casellas A, Pujol A, Visa J, Pelegrin M, et al. 2000. Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes. J Clin Invest 105:731-740.
16. Dodds EC, Lawson W. 1936. Synthetic oestrogenic agents without the phenantrene nucleus. Nature 137:996.
17. ECSCF. 2002. Opinion of the Scientific Committee on Food on Bisphenol A. SCF/CS/PM/3936 Final. Brussels:European Commission Scientific Committee on Food. Available: http://europa.eu.int/comm/food/fs/sc/scf/out128_en.pdf [accessed 31 August 2005].
18. Faure A, Haouari M, Sutter BC. 1985. Insulin secretion and biosynthesis after oestradiol treatment. Horm Metab Res 17:378.
19. Geisler JG, Zawalich W, Zawalich K, Lakey JR, Stukenbrok H, Milici AJ, et al. 2002. Estrogen can prevent or reverse obesity and diabetes in mice expressing human islet amyloid polypeptide. Diabetes 51:2158-2169.
20. Heindel JJ. 2003. Endocrine disruptors and the obesity epidemic. Toxicol Sci 76:247-249.
21. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. 2000. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 97:12729-12734.
22. Hollingsworth DR. 1983. Alterations of maternal metabolism in normal and diabetic pregnancies: differences in insulin-dependent, non-insulin-dependent, and gestational diabetes. Am J Obstet Gynecol 146:417-429.
23. Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom Saal FS. 1999. Exposure to bisphenol A advances puberty. Nature 401:763-764.
24. Hunt PA, Koehler KE, Susiarjo M, Odges CA, Llagan A, Voigt RC, et al. 2003. Bisphenol A exposure causes meiotic aneuploidy in the female mouse. Curr Biol 13:546-553.
25. Ikezuki Y, Tsutsumi O, Takai Y, Kamei Y, Taketani Y. 2002. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod 17:2839-2841.
26. Johnson MD, Kenney N, Stoica A, Hilakivi-Clarke L, Singh B, Chepko G, et al. 2003. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med 9:1081-1084.
27. Livingstone C, Collison M. 2002. Sex esteroids and insulin resistance. Clin Sci 102:151-166.
28. Losel RM, Falkenstein E, Feuring M, Schultz A, Tillmann HC, Rossol-Haseroth K, et al. 2003. Nongenomic steroid action: controversies, questions, and answers. Physiol Rev 83:965-1016.
29. Louet JF, LeMay C, Mauvais-Jarvis F. 2004. Antidiabetic actions of estrogen: insights from humans and genetic mouse models. Curr Atheroscler Rep 6:180-185.
30. Marban SL, DeLoia JA, Gearhart JD. 1989. Hyperinsulinemia in transgenic mice carrying multiple copies of the human insulin gene. Dev Genet 10:356-364.
31. Masuno H, Kidani T, Sekiya K, Sakayama K, Shiosaka T, Yamamoto H. 2002. Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J Lipid Res 43:676-684.
32. McGurry JD. 1992. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258:766-770.
33. McLachlan JA. 2001. Environmental signaling: what embryos and evolution teach us about endocrine disrupting chemicals. Endocr Rev 22:319-341.
34. McLusky NJ, Hajszan T, Leranth C. 2005. The environmental estrogen bisphenol A inhibits estrogen-induced hippocampal synaptogenesis. Environ Health Perspect 113:675-679; doi:10.1289/ehp.7633 [Online 24 February 2005].
35. Mead MN. 2004. Origins of obesity. Environ Health Perspect 112:A344.
36. Morimoto S, Fernandez-Mejia C, Romero-Navarro G, Morales-Peza N, Diaz-Sanchez V. 2001. Testosterone effect on insulin content, messenger ribonucleic acid levels, promoter activity, and secretion in the rat. Endocrinology 142:1442-1447.
37. Nadal A, Alonso-Magdalena P, Ripoll C, Fuentes E. 2005. Disentangling the molecular mechanism of action of natural and environmental estrogens. Pflugers Arch 449:335-343.
38. Nadal A, Ropero AB, Fuentes E, Soria B, Ripoll C. 2004. Estrogen and xenoestrogen actions on endocrine pancreas: from ion channel modulation to activation of nuclear function. Steroids 69:531-536.
39. Nadal A, Ropero AB, Laribi O, Maillet M, Fuentes E, Soria B. 2000. Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor alpha and estrogen receptor beta. Proc Natl Acad Sci USA 97:11603-11608.
40. Nadal A, Rovira JM, Laribi O, Leon-Quinto T, Andreu E, Ripoll C, et al. 1998. Rapid insulinotropic effect of 17beta-estradiol via a plasma membrane receptor. FASEB J 12:1341-1348.
41. Newbold RR. 2004. Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol Appl Pharmacol 199:142-150.
42. Perez-Martin M, Azcoitia I, Trejo JL, Sierra A, Garcia-Segura LM. 2003. An antagonist of estrogen receptors blocks the induction of adult neurogenesis by insulin-like growth factor-I in the dentate gyrus of adult female rat. European J Neurosci 18:923-930.
43. Pontiroli AE, Alberetto M, Pozza G. 1992. Patients with insulinoma show insulin resistance in the absence of arterial hypertension. Diabetologia 35:294-295.
44. Quesada I, Fuentes E, Viso-Leon MC, Soria B, Ripoll C, Nadal A. 2002. Low doses of the endocrine disruptor bisphenol-A and the native hormone 17beta-estradiol rapidly activate transcription factor CREB. FASEB J 16:1671-1673.
45. Remillard RBJ, Bunce NJ. 2002. Linking dioxins to diabetes: epidemiology and biologic plausibility. Environ Health Perspect 110:853-858.
46. Ropero AB, Soria B, Nadal A. 2002. A nonclassical estrogen membrane receptor triggers rapid differential actions in the endocrine pancreas. Mol Endocrinol 16:497-505.
47. Sakurai K, Kawazuma M, Adachi T, Harigaya T, Saito Y, Hashimoto N, et al. 2004. Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br J Pharmacol 141:209-214
48. Schonfelder G, Wittfoht W, Hopp H, Talsness CE, Paul M, Chahoud I. 2002. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Perspect 110:A703-A707.
49. Skrha J, Sindelka G, Haas T, Hilgertova J, Justova V. 1996. Comparison of insulin sensitivity in patients with insulinoma and obese type 2 diabetes mellitus. Horm Metab Res 28:595-598.
50. Song M, Helguera G, Eghbali M, Zhu N, Zarei MM, Olcese R, et al. 2001. Remodeling of Kv4.3 potassium channel gene expression under the control of sex hormones. J Biol Chem 276:31883-31890.
51. Srivastava DP, Yu EJ, Kennedy K, Chatwin H, Reale V, Hamon M, et al. 2005. Rapid, nongenomic responses to ecdysteroids and catecholamines mediated by a novel drosophila G-protein-coupled receptor. J Neurosci 25:6145-6155.
52. Sutter-Dub MT. 2002. Rapid non-genomic and genomic responses to progestogens, estrogens, and glucocorticoids in the endocrine pancreatic B cell, the adipocyte and other cell types. Steroids 67:77-93.
53. vom Saal FS, Cooke PS, Buchanan DL, Palanza P, Thayer KA, Nagel SC, et al. 1998. A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production and behavior. Toxicol Ind Health 14:239-260.
54. vom Saal FS, Hughes C. 2005. An extensive new literature concerning low-dose effects of bisphenol-A shows the need for a new risk assessment. Environ Health Perspect 113:926-933; doi:10.1289/ehp.7713 [Online 13 April 2005]
55. World Health Organization. 2005. Welcome to the Diabetes Program. Available: http://www.who.int/diabetes/en/ [accessed 23 November 2005].
56. 2+ fluxes and prolactin release in GH3/B6 pituitary tumor cells. Environ Health Perspect 113:431-439; doi:10.1289/ehp.7505 [Online 14 January 2005].
57. Zalko D, Soto AM, Dolo L, Dorio C, Rathahao E, Debrauwer L, et al. 2003. Biotransformations of bisphenol A in a mammalian model: answers and new questions raised by low-dose metabolic fate studies in pregnant CD1 mice. Environ Health Perspect 111:309-319.